(Shanghai / Beijing Comprehensive News) A test institution in Xuchang, Henan Province, did not receive a repayment of various districts and counties, originally planned to suspend receiving nucleic acid samples, which aroused external attention. On Wednesday (November 9)problem solved.

According to the Daily Economic News report, Xuchang Bo Runkang Medical Inspection Labs suspended the screenshot of the notification of the acceptance of crown disease nucleic acid samples, which spread on Tuesday.Large -scale nucleic acid testing tasks, reagent consumables, labor and investment costs are high. At present, all districts and counties have not remitted money in time, resulting in too much pressure on the institution.

Screenshots show that the company receives a notice of headquarters that it will suspend the acceptance of all crowrium nucleic acid samples from Xuchang counties and districts from 00:00 on Friday (November 11).

The normalized nucleic acid testing expenses under the prevention and control of China's epidemic are borne by governments at all levels. This huge expenditure has made it overwhelmed by many places. The above notice once again triggered the discussion of financial pressure on large -scale nucleic acid testing to various places.

After attracting the attention of the outside world, the Xuchang Bo Runkang Medical Inspection Lab issued a statement on Wednesday stating that after communicating with relevant parties, the problem of nucleic acid repayment of the agency has been effectively resolved.

Under normalized testing, China has recently announced the restoration of nucleic acid testing fees.

According to the news of the Health Client of the People's Daily, Sichuan, Gansu, Guizhou and other places have issued notifications. From November, nucleic acid testing should be recovered, and the charging standards in various places are different. Among them, single -person single inspection costs are mostly 16 yuan per person.(RMB, the same below, S $ 3), multi -person mixes of 3.5 yuan to 5 yuan per person.